Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program | Zendy

William M. Steinberg | Zendy; Julio Rosenstock | Zendy; Thomas A. Wadden | Zendy; Morten Donsmark | Zendy; Christine B. Jensen | Zendy; J. Hans DeVries | Zendy

Open Access

Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program

Author(s) -

William M. Steinberg,

Julio Rosenstock,

Thomas A. Wadden,

Morten Donsmark,

Christine B. Jensen,

J. Hans DeVries

Publication year - 2017

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc16-2684

Subject(s) - medicine , liraglutide , prediabetes , diabetes mellitus , overweight , type 2 diabetes , obesity , pancreatitis , endocrinology

To describe amylase/lipase activity levels and events of acute pancreatitis (AP) in the SCALE (Satiety and Clinical Adiposity-Liraglutide Evidence in individuals with and without diabetes) weight-management trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research